53. BenMohamed, L., et al., Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses. Immunology, 2002. 106(1): p. 113-21. 54. Pepperl -Klindworth, S., N. Frankenberg, and B. Plachter, Development of novel vaccine strategies against human cytomegalovirus infection based on subviral particles. Journal of Clinical Virology, 2002. 25 Suppl 2 : p. S75-85. Pro00065241: AVERT Version: 20170 315 Duke Cancer Institute CONFIDENTIAL Page 56 55. Britt, W., et al., Fo rmulation of an immunogenic human cytomegalovirus vaccine: responses in mice. Journal of Infectious Diseases, 1995. 171(1): p. 18-25.